Vyant Bio, Inc.

( )
CGIX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Technology Services » Internet Software Or Services
FBFacebook, Inc. -3.66%340.650.7%$5330.82m
GOOGLAlphabet, Inc. -3.72%2716.600.5%$3589.83m
GOOGAlphabet, Inc. -3.76%2723.680.5%$3122.78m
AFRMAffirm Holdings, Inc. -10.79%114.520.0%$1997.27m
UPSTUpstart Holdings, Inc. -5.60%313.400.0%$1650.98m
SESea Ltd. (Singapore) -5.81%316.723.1%$1335.56m
SNAPSnap, Inc. -7.08%74.412.3%$1188.13m
MTCHMatch Group, Inc. -4.95%156.494.4%$1126.49m
DASHDoorDash, Inc. -4.77%206.390.0%$749.22m
BIDUBaidu, Inc. -1.86%154.022.3%$693.25m
TWTRTwitter, Inc. -4.53%62.418.8%$648.76m
DKNGDraftKings, Inc. -2.84%49.930.0%$634.72m
MELIMercadoLibre, Inc. -4.87%1682.013.6%$490.72m
FUTUFutu Holdings Ltd. -4.67%88.860.0%$437.23m
MSTRMicroStrategy, Inc. -3.57%573.513.0%$410.40m

Company Profile

Vyant Bio, Inc. is emerging as an advanced biotechnology drug discovery company. The firm is focused on human-powered scientific and technology-based systems to de-risk and accelerate the discovery and development of therapeutics for biopharma partners, as well as for its proprietary pipeline. The company with capabilities in data, science (both biology and chemistry), engineering, and regulatory, it rapidly identifying small and large molecule therapeutics and derisking decision making through multiple in silico, in vitro, and in vivo modalities. It leveraging these modalities, the company is able to capitalize on repurposed and novel compounds and then partner with others to further develop and commercialize valuable therapeutics and new treatments for patients. It operates two wholly-owned subsidiaries, StemoniX and vivoPharm. Vyant Bio was founded in 1999 and is headquartered in Cherry Hill, NJ.